BHILWARA SP. | DR HABEEBULLAH LIFE SCIENCES | BHILWARA SP./ DR HABEEBULLAH LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 43.3 | -114.9 | - | View Chart |
P/BV | x | 2.9 | 2.3 | 126.0% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
BHILWARA SP. DR HABEEBULLAH LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
BHILWARA SP. Mar-24 |
DR HABEEBULLAH LIFE SCIENCES Mar-24 |
BHILWARA SP./ DR HABEEBULLAH LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 160 | 28 | 561.6% | |
Low | Rs | 37 | 13 | 284.6% | |
Sales per share (Unadj.) | Rs | 10.4 | 0 | - | |
Earnings per share (Unadj.) | Rs | 1.9 | -0.2 | -1,135.1% | |
Cash flow per share (Unadj.) | Rs | 1.9 | -0.2 | -1,162.1% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 48.2 | 8.3 | 581.8% | |
Shares outstanding (eoy) | m | 9.05 | 14.81 | 61.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 9.5 | 0 | - | |
Avg P/E ratio | x | 51.4 | -122.8 | -41.9% | |
P/CF ratio (eoy) | x | 50.8 | -124.1 | -40.9% | |
Price / Book Value ratio | x | 2.0 | 2.5 | 81.6% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 891 | 307 | 290.3% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 1 | 140.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 94 | 0 | - | |
Other income | Rs m | 1 | 0 | - | |
Total revenues | Rs m | 96 | 0 | - | |
Gross profit | Rs m | 21 | -2 | -840.2% | |
Depreciation | Rs m | 0 | 0 | 1,050.0% | |
Interest | Rs m | 1 | 0 | 10,100.0% | |
Profit before tax | Rs m | 21 | -3 | -838.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 4 | 0 | - | |
Profit after tax | Rs m | 17 | -3 | -693.6% | |
Gross profit margin | % | 22.0 | 0 | - | |
Effective tax rate | % | 17.2 | 0 | - | |
Net profit margin | % | 18.4 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 174 | 55 | 316.9% | |
Current liabilities | Rs m | 35 | 32 | 109.1% | |
Net working cap to sales | % | 148.3 | 0 | - | |
Current ratio | x | 5.0 | 1.7 | 290.4% | |
Inventory Days | Days | 74 | 0 | - | |
Debtors Days | Days | 20,113 | 0 | - | |
Net fixed assets | Rs m | 805 | 101 | 800.6% | |
Share capital | Rs m | 91 | 148 | 61.1% | |
"Free" reserves | Rs m | 345 | -26 | -1,353.4% | |
Net worth | Rs m | 436 | 123 | 355.5% | |
Long term debt | Rs m | 506 | 0 | - | |
Total assets | Rs m | 979 | 156 | 629.5% | |
Interest coverage | x | 21.7 | -248.0 | -8.8% | |
Debt to equity ratio | x | 1.2 | 0 | - | |
Sales to assets ratio | x | 0.1 | 0 | - | |
Return on assets | % | 1.9 | -1.6 | -117.3% | |
Return on equity | % | 4.0 | -2.0 | -195.2% | |
Return on capital | % | 2.3 | -2.0 | -115.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -101 | -1 | 7,817.1% | |
From Investments | Rs m | -582 | NA | - | |
From Financial Activity | Rs m | 654 | 1 | 51,091.4% | |
Net Cashflow | Rs m | -29 | 0 | 285,000.0% |
Indian Promoters | % | 50.9 | 52.9 | 96.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.9 | 0.0 | - | |
FIIs | % | 0.9 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 49.1 | 47.1 | 104.1% | |
Shareholders | 7,878 | 2,740 | 287.5% | ||
Pledged promoter(s) holding | % | 0.0 | 5.1 | - |
Compare BHILWARA SP. With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA UNIPHOS ENT
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | BHILWARA SP. | DR HABEEBULLAH LIFE SCIENCES |
---|---|---|
1-Day | -1.36% | 1.96% |
1-Month | -4.57% | -21.46% |
1-Year | 93.35% | 17.95% |
3-Year CAGR | 94.06% | -7.54% |
5-Year CAGR | 81.05% | -21.83% |
* Compound Annual Growth Rate
Here are more details on the BHILWARA SP. share price and the DR HABEEBULLAH LIFE SCIENCES share price.
Moving on to shareholding structures...
The promoters of BHILWARA SP. hold a 50.9% stake in the company. In case of DR HABEEBULLAH LIFE SCIENCES the stake stands at 52.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of BHILWARA SP. and the shareholding pattern of DR HABEEBULLAH LIFE SCIENCES.
Finally, a word on dividends...
In the most recent financial year, BHILWARA SP. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
DR HABEEBULLAH LIFE SCIENCES paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of BHILWARA SP., and the dividend history of DR HABEEBULLAH LIFE SCIENCES.
For a sector overview, read our textiles sector report.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.